22 May 2013
Keywords: Sigma-Tau, Anti-malarial, Eurartesim, Research
Article | 28 September 2009
Results from Phase III clinical trials conducted on over 2,500 patients in Africa and Asia, of whom 1,600 were children aged under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 September 2009
© 2013 thepharmaletter.com